Evidence map›Paper›PMID 38269198›Full record

ReviewIranian journal of biotechnology2023

Introns and Their Therapeutic Applications in Biomedical Researches.

Aliakbar Haddad-Mashadrizeh, Mahdi Mirahmadi, Mohammad Ehsan Taghavizadeh Yazdi, Nazanin Gholampour-Faroji, Ahmadreza Bahrami, Alireza Zomorodipour, Maryam Moghadam Matin, Mohsen Qayoomian, Neda Saebnia

Open access · greenAbstract readReview
In one paragraph

Review in Iranian journal of biotechnology, 2023. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 4 papers.

0numbers the graph read from it
0cells of the map it votes in
4citing papers in PubMed
0.8field-weighted citation impact, top 26% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

4 citing papers in PubMed, 5 citations in OpenAlex.

  1. Article
  2. Article
  3. Article
  4. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

9 authors at 4 institutions in 1 country.

Aliakbar Haddad-MashadrizehIndustrial Biotechnology Research Group, Institute of Biotechnology, Ferdowsi University of Mashhad, Mashhad, Iran.
Mahdi MirahmadiStem Cell and Regenerative Medicine Research Group, Iranian Academic Center for Education, Culture and Research (ACECR), Khorasan Razavi Branch, Mashhad, Iran.
Mohammad Ehsan Taghavizadeh YazdiApplied Biomedical Research Center, Mashhad University of Medical Sciences, Mashhad, Iran.
Nazanin Gholampour-FarojiIndustrial Biotechnology Research Group, Institute of Biotechnology, Ferdowsi University of Mashhad, Mashhad, Iran.
Ahmadreza BahramiIndustrial Biotechnology Research Group, Institute of Biotechnology, Ferdowsi University of Mashhad, Mashhad, Iran.
Alireza ZomorodipourNational Institute for Genetic Engineering and Biotechnology, Tehran, Iran.
Maryam Moghadam MatinDepartment of Biology, Faculty of Science, Ferdowsi University of Mashhad, Mashhad, Iran.
Mohsen QayoomianApplied Biomedical Research Center, Mashhad University of Medical Sciences, Mashhad, Iran.
Neda SaebniaDepartment of Biology, Faculty of Science, Ferdowsi University of Mashhad, Mashhad, Iran.
Ferdowsi University of Mashhad · IRMashhad University of Medical Sciences · IRBiotechnology Research Center · IRNational Institute of Genetic Engineering and Biotechnology · IR

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

Context: Although for a long time, it was thought that intervening sequences (introns) were junk DNA without any function, their critical roles and the underlying molecular mechanisms in genome regulation have only recently come to light. Introns not only carry information for splicing, but they also play many supportive roles in gene regulation at different levels. They are supposed to function as useful tools in various biological processes, particularly in the diagnosis and treatment of diseases. Introns can contribute to numerous biological processes, including gene silencing, gene imprinting, transcription, mRNA metabolism, mRNA nuclear export, mRNA localization, mRNA surveillance, RNA editing, NMD, translation, protein stability, ribosome biogenesis, cell growth, embryonic development, apoptosis, molecular evolution, genome expansion, and proteome diversity through various mechanisms. Evidence Acquisition: In order to fulfill the objectives of this study, the following databases were searched: Medline, Scopus, Web of Science, EBSCO, Open Access Journals, and Google Scholar. Only articles published in English were included. Results & Conclusions: The intervening sequences of eukaryotic genes have critical functions in genome regulation, as well as in molecular evolution. Here, we summarize recent advances in our understanding of how introns influence genome regulation, as well as their effects on molecular evolution. Moreover, therapeutic strategies based on intron sequences are discussed. According to the obtained results, a thorough understanding of intron functional mechanisms could lead to new opportunities in disease diagnosis and therapies, as well as in biotechnology applications.

Indexed as

Gene regulationIntronJunk DNAMolecular evolutionTherapeutic application

Identifiers

PMID38269198
PMCPMC10804063
OpenAlexW4391233202

What OpenQuestion holds

Textmetadata
LicenceCC BY-NC
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.